What Is the Cost of a Mammogram With and Without Insurance?

Most people with private health insurance or Medicare pay nothing out of pocket for a routine screening mammogram, thanks to federal rules that eliminate copays and deductibles for preventive care. Without insurance, the picture changes dramatically: cash prices at major hospitals average around $305, but the sticker price on a hospital’s chargemaster can exceed $850 for the same service. The gap between what insured and uninsured patients face is real, but the details are more layered than a single number can capture, and several common situations can generate surprise bills even for insured patients.

What Most Insurance Plans Cover at No Cost

Since September 2010, the Affordable Care Act has required most health insurance policies to cover evidence-based preventive services with no cost-sharing, meaning no copays, coinsurance, or deductibles for the patient.1Medical Care. The ACA’s Zero Cost-Sharing Mandate and Trends in Out-of-Pocket Expenditures on Well-Child and Screening Mammography Visits Screening mammography is one of those covered services. If you have a plan that complies with the ACA, whether purchased through an employer, a marketplace exchange, or individually, a routine screening mammogram should cost you zero dollars at the point of care. Medicare also covers annual screening mammograms for women 40 and older with no copay or deductible.

This zero-cost provision has had a measurable effect on who gets screened. Research has found that eliminating deductibles for preventive care boosts mammography rates, with larger effects among women with lower education levels and incomes.2PubMed Central. Health Insurance Mandates, Mammography, and Breast Cancer Diagnoses When price is not a barrier, more women show up. The policy works as intended for standard screening, but the protection has clear boundaries that catch many patients off guard.

When You Might Still Get a Bill

The ACA’s zero-cost guarantee applies only to screening mammograms, not to every mammogram. That distinction trips up a lot of people. A screening mammogram is the routine exam you schedule when you have no symptoms and no known problems. A diagnostic mammogram is ordered when something has been found: an abnormal screening result, a lump you or your doctor noticed, or a symptom like nipple discharge. Diagnostic mammograms, along with any follow-up ultrasounds, MRIs, or biopsies, can be billed under your plan’s regular cost-sharing rules, meaning copays, coinsurance, and deductible all apply.3PubMed. Effect of Out-of-Pocket Costs on Subsequent Mammography Screening

This matters more than it sounds. Roughly one in ten screening mammograms leads to a callback for additional imaging, and those follow-up tests are typically classified as diagnostic. So you can walk in for a free screening and walk out facing hundreds of dollars in diagnostic imaging costs if something looks abnormal. Several states have started passing laws to close this gap by requiring insurers to cover diagnostic mammograms at no cost, but coverage varies depending on where you live and what plan you carry.

There is another exception that still lingers. “Grandfathered” health plans, those that existed before March 23, 2010, and have not been substantially changed, are not required to comply with the ACA’s preventive care mandate. If your employer’s plan is grandfathered, you could be responsible for copays or coinsurance on even a routine screening mammogram. The number of grandfathered plans has shrunk considerably over the years, but some still exist, and people enrolled in them are often unaware of the coverage gap.

What Uninsured Patients Pay

If you do not have insurance and need a mammogram, the price you see depends heavily on where you go and how you ask. A study examining ten major U.S. hospitals found that the average chargemaster rate for a screening mammogram was $855.4Clinical Cancer Research. Assessing the True Cost of Breast Cancer Screening: Chargemaster, Payer, and Cash Price Discrepancies for Mammography The chargemaster is a hospital’s master list of prices before any negotiation happens, and almost nobody actually pays it. Insurance companies negotiate those rates down, and most hospitals offer discounted cash-pay rates for uninsured patients who ask.

At those same hospitals, the average cash price was $305, which is roughly a third of the chargemaster figure. The average price that insurers had negotiated with those hospitals was $411, meaning the cash price was actually about 74% of what insurance companies were paying. In other words, if you pay cash and ask for the self-pay rate, you may end up paying less than your insurer would have been billed. That said, these are averages across a small set of hospitals, and prices varied widely from one facility to the next, with a spread of about $200 in cash prices alone.

Independent imaging centers and community clinics tend to charge less than large hospital systems. It is not unusual to find a screening mammogram at a freestanding radiology center for $100 to $250 in many parts of the country, though prices can climb higher in expensive metro areas. Always call ahead and ask for the self-pay or cash-pay rate explicitly; the first number a billing office quotes may be the chargemaster price, which is almost never the final number anyone pays.

How Location Changes the Price

Geography is one of the biggest drivers of mammogram costs in the United States, and the differences are striking. Among privately insured women, the cost of a standard two-dimensional screening mammogram varied from $107 to $471 depending on the hospital referral region. For 3D mammography, the range was even wider: $113 to $714.5PubMed Central. Understanding regional variation in the cost of breast cancer screening among privately insured women in the United States The overall cost of breast cancer screening per woman screened averaged $353 but ranged from $174 to $367 at the interquartile level, meaning the middle half of regions already showed a twofold spread.

Medicare data tells a similar story, though at lower absolute price levels. Among Medicare beneficiaries, the screening-related cost per woman ranged from about $40 to $110 across hospital referral regions, with a median of about $64.6JAMA Internal Medicine. The Cost of Breast Cancer Screening in the Medicare Population That nearly threefold difference within a single federal insurance program reflects differences in practice patterns, imaging technology choices, and local pricing rather than any inherent difference in the procedure itself.

What drives this variation? The single biggest factors were the unit costs of 2D and 3D mammography, which together accounted for nearly half of the regional differences in per-patient spending. Biopsy costs contributed another chunk.5PubMed Central. Understanding regional variation in the cost of breast cancer screening among privately insured women in the United States If you live in a high-cost region and are paying out of pocket, it can be worth checking what facilities in neighboring areas charge. A thirty-minute drive could save you hundreds of dollars.

3D Mammography and What It Adds to the Bill

Three-dimensional mammography, also called digital breast tomosynthesis or DBT, has become increasingly common. Many facilities now use it as the default screening technology rather than standard 2D digital mammography. For Medicare patients, the reimbursement for a 2D mammogram was about $140, with an additional $56 for the 3D component, bringing the total to roughly $197.7JNCI: Journal of the National Cancer Institute. Long-Term Outcomes and Cost-Effectiveness of Breast Cancer Screening With Digital Breast Tomosynthesis in the United States Those are Medicare rates, which tend to be on the lower end of what facilities charge.

A number of states have passed laws requiring insurers to cover 3D mammography without extra cost-sharing, and most major private plans now include it. When researchers looked at the effect of those state mandates, they found that few women were paying out of pocket for 3D mammography even before the mandates passed, and the mandates did not significantly change out-of-pocket costs.8JAMA Network Open. Insurance Coverage Mandates and the Adoption of Digital Breast Tomosynthesis For most insured patients, 3D mammography is now effectively free for screening. For uninsured patients paying cash, the additional cost of 3D over 2D is typically modest, in the range of $50 to $100 more, though this varies by facility.

The Real Cost Problem Happens After the Screening

Where costs start to accumulate in a way that matters for real people is not the screening itself but everything that can follow. If your screening mammogram shows something that needs a closer look, you enter the diagnostic pipeline: additional mammographic views, ultrasound, possibly MRI, possibly biopsy. Each of these can trigger cost-sharing under your insurance plan, and the total adds up quickly.

Research has shown that the type of insurance plan you have influences whether you actually follow through on that recommended follow-up. Women enrolled in high-deductible health plans experienced measurable delays in getting diagnostic imaging, biopsies, and even early-stage cancer diagnoses compared to women in plans with lower deductibles.9PubMed Central. Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment High-deductible plan members were also slower to start chemotherapy when cancer was found. The screening itself was free, but the cost of acting on its results created a financial barrier that delayed care at the worst possible moment.

Another study examining different plan structures found that women in plans with higher cost-sharing consistently underwent fewer follow-up imaging procedures. Plans dominated by copays or deductibles were associated with fewer subsequent breast imaging procedures per thousand patients than low cost-sharing plans. The pattern held for diagnostic mammograms and ultrasound specifically.10JAMA Network Open. Patient Cost-Sharing and Utilization of Breast Cancer Diagnostic Imaging by Patients Undergoing Subsequent Testing After a Screening Mammogram One notable finding: biopsy rates were not significantly different across plan types, suggesting that when the clinical stakes are unmistakably high, patients push through the cost barrier. But the intermediate steps, the imaging that determines whether a biopsy is needed, are where cost-sharing does its damage.

Free and Low-Cost Options for Uninsured Women

If you are uninsured or underinsured, several programs exist specifically to help cover the cost of breast cancer screening. The most established is the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), a CDC-funded initiative that provides free mammograms, Pap tests, and diagnostic services to eligible women. Eligibility generally includes women aged 40 to 64 with household incomes below 250% of the federal poverty level who lack health insurance.11PubMed Central. Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (United States)

The program operates through state and tribal health agencies and has been credited with significantly reducing breast cancer mortality among low-income and uninsured women over its history.12PubMed. The National Breast and Cervical Cancer Early Detection Program: 25 Years of public health service to low-income women However, the program has historically been able to serve only a fraction of eligible women. In one assessment period, roughly four million women met the program’s eligibility criteria, but only about 529,000 received a funded mammogram, covering around 13% of those who qualified.11PubMed Central. Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (United States) Funding limits the number of women who can be served, so applying early in the fiscal year can improve your chances of getting a slot.

Beyond the NBCCEDP, many hospitals and imaging centers run their own charity care or sliding-scale programs. Nonprofits like Susan G. Komen and local breast cancer coalitions sometimes offer vouchers or direct payment for mammograms. Planned Parenthood locations in some states provide breast exams and can connect patients with mammography resources. Federally Qualified Health Centers, which serve patients regardless of ability to pay, can also arrange imaging at reduced cost. If you are uninsured, it is worth calling your state’s NBCCEDP coordinator, checking with local nonprofits, and asking imaging centers directly about financial assistance before assuming you cannot afford a mammogram.

Cost Perception Is Often Worse Than Reality

One of the most consistent findings in the research is that many women overestimate how much a mammogram costs, and that overestimation itself becomes a barrier to getting screened. In a study of underserved women, a majority cited cost as the reason they had not had a mammogram. But more than half of those women overestimated the actual out-of-pocket cost of the screening, and the higher their estimate, the more likely they were to skip it. Women who guessed their cost would exceed $50 were dramatically more likely to see cost as a barrier than women who estimated lower or knew the true price.13PubMed Central. Cost as a barrier to screening mammography among underserved women

Broader survey data reinforces the pattern from a different angle. Women who reported worrying about paying medical bills, struggling to afford dental care, or skipping medication doses to save money were all significantly less likely to have received a screening mammogram.14PubMed. Impact of Health Care-Associated Cost Concerns on Mammography Utilization: Cross-Sectional Survey Results From the National Health Interview Survey The relationship is not simply about whether someone can afford a mammogram; it is about whether the general financial stress of healthcare costs spills over into avoidance of preventive care. A person juggling which prescriptions to fill may not have the mental bandwidth to investigate whether their screening mammogram is actually free.

Insurance status itself is a strong predictor of whether women receive guideline-recommended mammograms. Women with private insurance and Medicare beneficiaries were both roughly 60 to 65% more likely to have received a mammogram consistent with current guidelines compared to uninsured women. Those experiencing financial hardship had about 30% lower odds of getting a guideline-concordant mammogram even when they had insurance.15AACR Journals (Cancer Epidemiology, Biomarkers & Prevention). Associations between Insurance Status, Financial Hardship, and Rurality on Receipt of Guideline-Concordant Mammography Financial stress operates independently of actual coverage, which means information alone does not solve the problem, but it does help close the gap for women who do have coverage and simply do not realize their screening is free.

Using Price Transparency Tools

Hospitals and insurers have increasingly been required to publish pricing information, and many insurance companies now offer online cost-estimator tools. These tools let you look up a specific procedure and see an estimate of what you will owe, factoring in your plan’s deductible status and cost-sharing structure. When researchers tested one such estimator in a large health system, they found that about 84% of the estimates were accurate when compared to the actual bills patients received.16PubMed Central. Assessment of Accuracy and Usability of a Fee Estimator for Ambulatory Care in an Integrated Health Care Delivery Network That is reasonably reliable, but it still means about one in six estimates was off, so treat these numbers as useful ballpark figures rather than guarantees.

Federal price transparency rules now require hospitals to publish their standard charges, including negotiated rates with specific insurers and discounted cash prices, in machine-readable files. In practice, these files are often hard to navigate and may not reflect the final price you pay after all the billing codes are applied. The most practical approach for an uninsured patient is still to call the facility’s billing department directly, ask for the self-pay rate for a screening mammogram (specify the CPT code 77067 for a 2D digital screening mammogram if you want to be precise), and ask whether any financial assistance programs apply. For insured patients, calling your insurer to confirm that the specific facility is in-network and that the procedure will be coded as a screening (not diagnostic) mammogram is the single most effective step to avoid an unexpected bill.

Why the Screening Versus Diagnostic Label Matters So Much

The billing distinction between screening and diagnostic mammography deserves extra attention because it is the single most common source of surprise costs. Imagine this scenario: you go in for your annual screening, the radiologist sees something and wants to take additional images right then, and the visit is recoded from screening to diagnostic before you leave the building. You walked in expecting a free exam and receive a bill weeks later because the additional views were classified under a diagnostic code. This happens routinely, and most patients do not learn about it until the explanation of benefits arrives.

Some facilities handle this more gracefully than others. A growing number of states have passed or introduced legislation requiring insurers to cover diagnostic mammograms at the same zero cost-sharing level as screening mammograms, recognizing that the current system punishes women for having an abnormality detected. At the federal level, a provision in a 2022 spending bill requires most private insurance plans to cover diagnostic breast imaging without cost-sharing, though the implementation timeline has allowed plans a transition period. If you are facing a bill for diagnostic imaging after a screening callback, it is worth checking whether your state has enacted its own protections and whether your plan has already adopted the updated federal requirements.

For uninsured women, the screening-versus-diagnostic distinction still matters because it affects what assistance programs will cover. The NBCCEDP covers not just screening mammograms but also diagnostic follow-up for women enrolled in the program, which is a meaningful advantage over programs that only pay for the initial screening. If you are uninsured and have a family history or other risk factors that make callbacks more likely, enrolling in a program that covers the full screening-to-diagnosis pipeline can save you from an unexpected financial burden down the road.